Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Crown Records Management
Crown Records Management
Activities:
Patient Experience
X
LinkedIn
Trending Articles
Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222
Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
CordenPharma & GENEPEP collaborate to leverage peptide drug substance discovery
The partnership has facilitated the expedition of the development, discovery and manufacturing of peptides for early clinical phase
ISPE announces 2024 Facility of the Year Awards category winners
The awards programme recognises pharmaceutical companies that are the 'best' in the industry for innovation, operations, digitalisation, supply chain and social impact
Tabletability, compactability and compressibility: What’s the difference?
To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be...
Chemistry, manufacturing and control (CMC) as key drivers for drug discovery success
Embracing collaborative strategies not only accelerates drug development programmes but also fosters science-based milestone decisions, mitigates risks and prepares for...
Upcoming event
Making Pharmaceuticals
23–24 April 2024 | Exhibition | Coventry, UK
See all
Related Content
Regulatory
Healthcare professionals express opinions on personal data
Professionals in the healthcare sector want their personal data edited or deleted when GDPR comes in
Digital
Data management in the future
Pharma leads the way in long-term digital preservation as the battle hots up to keep data readable in future
Digital
Ten ways to shine a light on dark data in pharmaceuticals and find value in it
How businesses can benefit from finally taking control of the great unknown
Regulatory
Pharma sector praised for bringing data protection reforms despite Brexit
Half of companies see Brexit as an opportunity for Britain to position itself as the safest place to do business
Regulatory
Why pharmaceutical companies should still prepare for EU General Data Protection Regulation in the new year – regardless of Brexit
Don’t give up on data reforms just because UK is quitting Europe
Subscribe now